Root and Catalyst Pharmaceuticals Set for Mid-Week Earnings Showdown
Root and Catalyst Pharmaceuticals are scheduled to report quarterly results on Wednesday, offering investors a dual look at high-growth technology and healthcare resilience. Both companies face critical tests regarding their respective expansion strategies and bottom-line improvements in a shifting macroeconomic environment.